 | | PRD_000973 | | Name: | Trypsin inhibitor 1 | | Formula: | C71 H103 N18 O18 S2 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001220 | | Name: | meta-guanidinomethyl-phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | | Formula: | C35 H57 N15 O4 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001221 | | Name: | phenylacetyl-Arg-Val-Arg-(amidomethyl)benzamidine | | Formula: | C33 H52 N12 O4 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001086 | | Name: | Microviridin J | | Formula: | C80 H108 N19 O22 | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_001218 | | Name: | Dityromycin | | Formula: | C67 H88 N10 O16 | | Description: | DITYROMYCIN WAS CLARIFIED TO BE COMPOSED OF N-MEVAL, PRO, VAL, PHENYLGLYCINE, CH3NH2, N,N-ME2THR AND DI-ALPHA-AMINO ACID CONTAINING DIPHENYLETHER MOIETY. | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_001211 | | Name: | LEDGF peptide | | Formula: | C27 H45 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2014-03-25 |
|
 | | PRD_001142 | | Name: | tyrocidine A | | Formula: | C66 H87 N13 O13 | | Definition date: | 2014-03-19 | | Last modified: | 2014-03-19 |
|
 | | PRD_001219 | | Name: | Lantibiotic 107891 | | Formula: | C94 H127 Cl N26 O26 S5 | | Description: | NAI-107 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR. | | Definition date: | 2014-03-05 | | Last modified: | 2014-03-05 |
|
 | | PRD_001104 | | Name: | cyclic peptide S2iL5 | | Formula: | C90 H126 F3 N27 O23 S | | Definition date: | 2014-02-19 | | Last modified: | 2014-02-19 |
|
 | | PRD_001185 | | Name: | CONANTOKIN BK-B | | Formula: | C46 H64 N10 O25 | | Definition date: | 2014-02-19 | | Last modified: | 2014-02-19 |
|
 | | PRD_001135 | | Name: | (CBZ)NPQ(B27) peptide | | Formula: | C26 H38 N6 O8 S | | Definition date: | 2014-02-12 | | Last modified: | 2014-02-12 |
|
 | | PRD_001166 | | Name: | bicyclic peptide UK749 | | Formula: | C71 H108 N25 O20 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_001167 | | Name: | bicyclic peptide UK811 | | Formula: | C74 H119 N26 O22 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_001168 | | Name: | bicyclic peptide UK903 | | Formula: | C72 H103 N19 O19 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_001173 | | Name: | Phosphothreonine ester-containing peptide | | Formula: | C44 H72 N8 O13 P | | Definition date: | 2013-10-30 | | Last modified: | 2014-01-23 |
|
 | | PRD_001212 | | Name: | LEDGF peptide | | Formula: | C28 H48 N9 O10 S2 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001213 | | Name: | PK(NLE)DN(DVA) peptide | | Formula: | C30 H51 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001214 | | Name: | PKIDN(DPR) peptide | | Formula: | C30 H49 N8 O9 | | Definition date: | 2013-12-25 | | Last modified: | 2013-12-25 |
|
 | | PRD_001156 | | Name: | PL-55 | | Formula: | C41 H67 N9 O12 P S | | Definition date: | 2013-12-11 | | Last modified: | 2013-12-11 |
|
 | | PRD_001159 | | Name: | PL-74 | | Formula: | C46 H74 N10 O13 P S | | Definition date: | 2013-12-11 | | Last modified: | 2013-12-11 |
|
 | | PRD_001130 | | Name: | SmBz, cyclosporin A derivative | | Formula: | C70 H118 N11 O14 | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_001187 | | Name: | pGly[807,811], a stapled myoA tail peptide | | Formula: | C98 H177 N31 O23 S | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_001188 | | Name: | hydrogen bond surrogate (HBS) myoA helix mimetic | | Formula: | C92 H167 N29 O22 S | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_000777 | | Name: | N-[(2S)-2-({N~5~-[(1E)-ethanimidoyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucine | | Formula: | C41 H69 N9 O9 | | Definition date: | 2013-10-30 | | Last modified: | 2013-10-30 |
|
 | | PRD_000778 | | Name: | N-[(2S)-2-({N~5~-[(1E)-ethanimidoyl]-L-ornithyl-L-valyl}amino)-3-phenylpropyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucine | | Formula: | C44 H67 N9 O9 | | Definition date: | 2013-10-30 | | Last modified: | 2013-10-30 |
|
